By Drug Target Review2025-01-23T08:00:09
Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying early biomarkers for Parkinson's disease (PD).
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2023-03-07T10:55:58
Sponsored by Agilent
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-02-07T15:25:20
Sponsored by Bio-Techne
Site powered by Webvision Cloud